Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 5:4:499-507.
doi: 10.1016/j.trci.2018.08.007. eCollection 2018.

Hearing treatment for reducing cognitive decline: Design and methods of the Aging and Cognitive Health Evaluation in Elders randomized controlled trial

Affiliations

Hearing treatment for reducing cognitive decline: Design and methods of the Aging and Cognitive Health Evaluation in Elders randomized controlled trial

Jennifer A Deal et al. Alzheimers Dement (N Y). .

Abstract

Introduction: Hearing impairment is highly prevalent and independently associated with cognitive decline. The Aging and Cognitive Health Evaluation in Elders study is a multicenter randomized controlled trial to determine efficacy of hearing treatment in reducing cognitive decline in older adults. Clinicaltrials.gov Identifier: NCT03243422.

Methods: Eight hundred fifty participants without dementia aged 70 to 84 years with mild-to-moderate hearing impairment recruited from four United States field sites and randomized 1:1 to a best-practices hearing intervention or health education control. Primary study outcome is 3-year change in global cognitive function. Secondary outcomes include domain-specific cognitive decline, incident dementia, brain structural changes on magnetic resonance imaging, health-related quality of life, physical and social function, and physical activity.

Results: Trial enrollment began January 4, 2018 and is ongoing.

Discussion: When completed in 2022, Aging and Cognitive Health Evaluation in Elders study should provide definitive evidence of the effect of hearing treatment versus education control on cognitive decline in community-dwelling older adults with mild-to-moderate hearing impairment.

Keywords: Clinical trials; Cognition; Dementia; Epidemiology; Hearing; Longitudinal study; Memory; Presbycusis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Participant screening and randomization: the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized trial. Strata defined by severity of hearing impairment, participant status (ARIC participant or recruited de novo), and field site.

References

    1. Loughrey D.G., Kelly M.E., Kelley G.A., Brennan S., Lawlor B.A. Association of age-related hearing loss with cognitive function, cognitive impairment, and dementia: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2017;144:115–126. - PMC - PubMed
    1. Livingston G., Sommerlad A., Orgeta V., Costafreda S.G., Huntley J., Ames D. Dementia prevention, intervention, and care. Lancet. 2017;390:2673–2734. - PubMed
    1. Lin F.R., Albert M. Hearing loss and dementia—who is listening? Aging Ment Health. 2014;18:671–673. - PMC - PubMed
    1. Lin F.R., Niparko J.K., Ferrucci L. Hearing loss prevalence in the United States. Arch Intern Med. 2011;171:1851–1852. - PMC - PubMed
    1. Goman A.M., Lin F.R. Prevalence of hearing loss by severity in the United States. Am J Public Health. 2016;106:1820–1822. - PMC - PubMed

Associated data